美国FDA计划加速药品的审批过程,从而更快的提高制药企业的生产能力且更快地向病人提供最新的治疗。这一变化表现为其战略计划的细微改 The U.S. FDA plans to speed up the approval process for pharmaceuticals to speed up the manufacturing capacity of pharmaceutical companies and to provide patients with up-to-date treatment more quickly. This change manifests itself as a subtle change to its strategic plan